Literature DB >> 33166764

Regulatory role of microRNAs on PTEN signaling.

Soudeh Ghafouri-Fard1, Atefe Abak2, Hamed Shoorei3, Mahdi Mohaqiq4, Jamal Majidpoor5, Arezou Sayad1, Mohammad Taheri6.   

Abstract

Phosphatase and tensin homolog (PTEN) gene encodes a tumor suppressor protein which is altered in several malignancies. This protein is a negative regulator of the PI3K/AKT signaling. Several transcription factors regulate the expression of PTEN in positive or negative directions. Moreover, numerous microRNAs (miRNAs) have functional interactions with PTEN and inhibit its expression. Suppression of PTEN can attenuate the response of cancer cells to chemotherapeutic agents. Based on the critical role of this tumor suppressor gene, the identification of negative regulators of its expression has practical significance particularly in the prevention and management of cancer. Meanwhile, the interaction between miRNAs and PTEN has functional consequences in non-malignant disorders including myocardial infarction, osteoporosis, cerebral ischemic stroke, and recurrent abortion. In the present review, we describe the role of miRNAs in the regulation of expression and activity of PTEN.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cancer; Disorder; PTEN; miRNA

Year:  2020        PMID: 33166764     DOI: 10.1016/j.biopha.2020.110986

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

Review 1.  Regulation of osteoclast-mediated bone resorption by microRNA.

Authors:  Ling Ji; Xinyi Li; Shushu He; Song Chen
Journal:  Cell Mol Life Sci       Date:  2022-05-10       Impact factor: 9.261

2.  LncRNA HOTAIR influences cell proliferation via miR-130b/PTEN/AKT axis in IDD.

Authors:  Wen-Kang Chen; Han-Jing Zhang; Ming-Xiang Zou; Cheng Wang; Yi-Guo Yan; Xin-Li Zhan; Xue-Lin Li; Wen-Jun Wang
Journal:  Cell Cycle       Date:  2022-01-02       Impact factor: 4.534

Review 3.  The Networks of Noncoding RNAs and Their Direct Molecular Targets in Myocardial Infarction.

Authors:  Shiqi Wang; Yang Wang; Hongxin Cheng; Qing Zhang; Chenying Fu; Chengqi He; Quan Wei
Journal:  Int J Biol Sci       Date:  2022-05-01       Impact factor: 10.750

Review 4.  Signal Transduction Regulators in Axonal Regeneration.

Authors:  Barbara Hausott; Rudolf Glueckert; Anneliese Schrott-Fischer; Lars Klimaschewski
Journal:  Cells       Date:  2022-05-04       Impact factor: 7.666

Review 5.  Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer.

Authors:  Ying Liu; Xiang Ao; Wanpeng Yu; Yuan Zhang; Jianxun Wang
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-19       Impact factor: 8.886

6.  MiR-499a prevents astrocytes mediated inflammation in ischemic stroke by targeting PTEN.

Authors:  Xiaoxiang Guan; Yiwei Zhang; Ilgiz Gareev; Ozal Beylerli; Xinyuan Li; Guitian Lu; Lin Lv; Xin Hai
Journal:  Noncoding RNA Res       Date:  2021-09-28

Review 7.  Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.

Authors:  Ying Liu; Xiang Ao; Yu Wang; Xiaoge Li; Jianxun Wang
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

8.  Development of New Thiophene-Containing Triaryl Pyrazoline Derivatives as PI3Kγ Inhibitors.

Authors:  Bing Yang; Bo Zhang; Qun Zhao; Jin Li; Yujun Shi
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

9.  Molecular mechanism of microRNA-26a regulation of phosphatase and tensin homolog gene in condyloma acuminatum and penile squamous cell carcinoma.

Authors:  Yayu Hu; Enping Hu; Xiangchuan Su; Xiangen Chen; Xiulin Tao; Xiaoli Ren
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

10.  MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route.

Authors:  Butong Sun; Nanjun Hu; Dan Cong; Kang Chen; Jun Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.